2022
DOI: 10.1038/s41598-022-21558-w
|View full text |Cite
|
Sign up to set email alerts
|

Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

Abstract: Optical coherence tomography angiography (OCT-A) allows the detection of retinal vessel density (VD) loss, which is a reflection of brain vascular pathology. We aimed to investigate differences in macular VD in the superficial plexus in a large cohort of individuals cognitively unimpaired (CU), with mild cognitive impairment due to Alzheimer´s disease (MCI-AD), MCI due to cerebrovascular pathology (MCI-Va), probable Alzheimer´s disease dementia (ADD) and Vascular Dementia (VaD). Clinical, demographical, ophtha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
7
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 69 publications
(69 reference statements)
3
7
1
Order By: Relevance
“…The majority of cohorts reported in the literature, though, were relatively small and the results have not been validated in larger studies. A recent publication from our group, using data from a large clinical cohort, detected higher macular VD in the superficial plexus in MCI due to AD patients compared to cognitively healthy individuals (Marquié et al, 2022), contrary to previous literature results. Importantly, the inclusion of AD biomarkers in OCT-A studies in order to further validate this technique is warranted for the development of the field.…”
Section: Introductioncontrasting
confidence: 99%
See 4 more Smart Citations
“…The majority of cohorts reported in the literature, though, were relatively small and the results have not been validated in larger studies. A recent publication from our group, using data from a large clinical cohort, detected higher macular VD in the superficial plexus in MCI due to AD patients compared to cognitively healthy individuals (Marquié et al, 2022), contrary to previous literature results. Importantly, the inclusion of AD biomarkers in OCT-A studies in order to further validate this technique is warranted for the development of the field.…”
Section: Introductioncontrasting
confidence: 99%
“…In particular, we investigated the association of macular VD in the superficial plexus quantified by OCT-A with the AT(N) classification based on cerebrospinal fluid (CSF) Aβ1-42, p181-tau and t-tau measurements. Our hypothesis was that MCI participants with an AD CSF profile (reduced Aβ and elevated tau) would show 10.3389/fnins.2023.1076177 higher macular VD measures than those participants with a normal CSF profile, in line with the results of a recent publication from our group (Marquié et al, 2022).…”
Section: Introductionsupporting
confidence: 82%
See 3 more Smart Citations